Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phathom Pharmaceuticals (PHAT) Non-Current Debt (2022 - 2025)

Historic Non-Current Debt for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Q3 2025 value amounting to $207.1 million.

  • Phathom Pharmaceuticals' Non-Current Debt rose 1784.79% to $207.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $207.1 million, marking a year-over-year increase of 1784.79%. This contributed to the annual value of $201.4 million for FY2024, which is 4611.58% up from last year.
  • Latest data reveals that Phathom Pharmaceuticals reported Non-Current Debt of $207.1 million as of Q3 2025, which was up 1784.79% from $205.1 million recorded in Q2 2025.
  • Phathom Pharmaceuticals' Non-Current Debt's 5-year high stood at $207.1 million during Q3 2025, with a 5-year trough of $91.0 million in Q1 2022.
  • Over the past 4 years, Phathom Pharmaceuticals' median Non-Current Debt value was $137.8 million (recorded in 2023), while the average stood at $141.3 million.
  • In the last 5 years, Phathom Pharmaceuticals' Non-Current Debt soared by 573.19% in 2023 and then skyrocketed by 7833.57% in 2024.
  • Over the past 4 years, Phathom Pharmaceuticals' Non-Current Debt (Quarter) stood at $95.3 million in 2022, then surged by 44.69% to $137.8 million in 2023, then soared by 46.12% to $201.4 million in 2024, then rose by 2.82% to $207.1 million in 2025.
  • Its Non-Current Debt was $207.1 million in Q3 2025, compared to $205.1 million in Q2 2025 and $203.2 million in Q1 2025.